Clinical Trial Update: ML-004 in Adolescents and Adults With Autism Spectrum Disorders (ASD) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for ML-004 in adolescents and adults with autism spectrum disorders; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• ML-004

Snippet

Sponsor: MapLight Therapeutics | Conditions: Autism Spectrum Disorder | Phase 2 | Status: ACTIVE_NOT_RECRUITING